Abbott Voluntarily Recalls Powder Formulas Manufactured at One Plant
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Adobe CFO Dan Durn to depart company in June 2026
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Abbott (ABT) Falls After Some Infant Formulas Recalled Amid Cronobacter, Salmonella Complaints
February 18, 2022 10:44 AM ESTAbbott (NYSE: ABT) shares down 2.5% Friday after it issued a voluntary recall of powder formulas, including Similac, Alimentum, and... More
